PRECIGEN, INC. Operating Leases, Rent Expense
PRECIGEN, INC. (PGEN) reported Operating Leases, Rent Expense of $13.08 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-01
- PRECIGEN, INC. operating leases, rent expense for the quarter ending 2018-12-31 was $3.20M, a 2.73% decline year-over-year.
- PRECIGEN, INC. operating leases, rent expense for the quarter ending 2018-09-30 was $3.29M, a 3.82% increase year-over-year.
- PRECIGEN, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $3.33M, a 44.87% increase year-over-year.
- PRECIGEN, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $3.26M, a 41.63% increase year-over-year.
- PRECIGEN, INC. operating leases, rent expense for fiscal 2018 was $13.08M, a 18.19% increase from fiscal 2017.
- PRECIGEN, INC. operating leases, rent expense for fiscal 2017 was $11.06M, a 28.76% increase from fiscal 2016.
- PRECIGEN, INC. operating leases, rent expense for fiscal 2016 was $8.59M, a 0.20% decline from fiscal 2015.
- PRECIGEN, INC. operating leases, rent expense for fiscal 2015 was $8.61M, a 1.16% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.49M derived: sum of 2 quarters · filed 2019-03-01 | $9.82M derived: sum of 3 quarters · filed 2019-03-01 | $13.08M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | $3.29M 10-Q · filed 2018-11-08 | $6.62M derived: sum of 2 quarters · filed 2018-11-08 | $9.87M 10-Q · filed 2018-11-08 | $13.17M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2018-06-30 | $3.33M 10-Q · filed 2018-08-13 | $6.59M 10-Q · filed 2018-08-13 | $9.88M derived: sum of 3 quarters · filed 2019-03-01 | $13.04M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2018-03-31 | $3.26M 10-Q/A · filed 2018-08-13 | $6.55M derived: sum of 2 quarters · filed 2019-03-01 | $9.72M derived: sum of 3 quarters · filed 2019-03-01 | $12.01M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.46M derived: sum of 2 quarters · filed 2019-03-01 | $8.76M derived: sum of 3 quarters · filed 2019-03-01 | $11.06M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $3.17M 10-Q · filed 2018-11-08 | $5.46M derived: sum of 2 quarters · filed 2018-11-08 | $7.77M 10-Q · filed 2018-11-08 | $9.95M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $2.30M 10-Q · filed 2018-08-13 | $4.60M 10-Q · filed 2018-08-13 | $6.78M derived: sum of 3 quarters · filed 2019-03-01 | $8.86M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $2.30M 10-Q/A · filed 2018-08-13 | $4.48M derived: sum of 2 quarters · filed 2019-03-01 | $6.56M derived: sum of 3 quarters · filed 2019-03-01 | $8.86M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.26M derived: sum of 2 quarters · filed 2019-03-01 | $6.56M derived: sum of 3 quarters · filed 2019-03-01 | $8.59M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $2.08M 10-Q · filed 2017-11-09 | $4.38M derived: sum of 2 quarters · filed 2017-11-09 | $6.41M 10-Q · filed 2017-11-09 | $8.47M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $2.30M 10-Q · filed 2017-08-09 | $4.33M 10-Q · filed 2017-08-09 | $6.40M derived: sum of 3 quarters · filed 2018-03-01 | $8.56M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $2.03M 10-Q · filed 2017-05-10 | $4.09M derived: sum of 2 quarters · filed 2018-03-01 | $6.26M derived: sum of 3 quarters · filed 2018-03-01 | $8.51M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $4.23M derived: sum of 2 quarters · filed 2018-03-01 | $6.48M derived: sum of 3 quarters · filed 2018-03-01 | $8.61M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $2.17M 10-Q · filed 2016-11-09 | $4.41M derived: sum of 2 quarters · filed 2016-11-09 | $6.55M 10-Q · filed 2016-11-09 | $9.81M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $2.25M 10-Q · filed 2016-08-09 | $4.38M 10-Q · filed 2016-08-09 | $7.64M derived: sum of 3 quarters · filed 2017-03-01 | $10.16M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $2.13M 10-Q · filed 2016-05-10 | $5.40M derived: sum of 2 quarters · filed 2017-03-01 | $7.91M derived: sum of 3 quarters · filed 2017-03-01 | $9.28M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.78M derived: sum of 2 quarters · filed 2017-03-01 | $7.14M derived: sum of 3 quarters · filed 2017-03-01 | $8.51M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $2.52M 10-Q · filed 2015-11-09 | $3.88M derived: sum of 2 quarters · filed 2015-11-09 | $5.25M 10-Q · filed 2015-11-09 | $6.59M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $1.36M 10-Q · filed 2015-08-10 | $2.73M 10-Q · filed 2015-08-10 | $4.07M derived: sum of 3 quarters · filed 2016-02-29 | $5.34M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $1.37M 10-Q · filed 2015-05-11 | $1.36M 10-Q · filed 2014-05-09 | $2.71M derived: sum of 2 quarters · filed 2016-02-29 | $3.98M derived: sum of 3 quarters · filed 2016-02-29 | $5.75M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.61M derived: sum of 2 quarters · filed 2016-02-29 | $4.38M derived: sum of 3 quarters · filed 2016-02-29 | $5.67M 10-K · filed 2016-02-29 | $5.58M 10-K · filed 2014-03-31 | |||
| 2013-09-30 | $1.30M 10-Q · filed 2014-11-13 | $3.04M derived: sum of 2 quarters · filed 2014-08-14 | $4.33M 10-Q · filed 2014-11-13 | $4.28M 10-Q · filed 2013-11-07 | $5.61M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | $1.77M 10-Q · filed 2014-08-14 | $1.74M 10-Q/A · filed 2013-10-21 | $3.04M 10-Q · filed 2014-08-14 | $3.01M 10-Q/A · filed 2013-10-21 | $4.34M derived: sum of 3 quarters · filed 2015-03-02 | $5.59M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $1.27M 10-Q · filed 2014-05-09 | $2.57M derived: sum of 2 quarters · filed 2015-03-02 | $3.83M derived: sum of 3 quarters · filed 2015-03-02 | $5.05M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.55M derived: sum of 2 quarters · filed 2015-03-02 | $3.78M derived: sum of 3 quarters · filed 2015-03-02 | $5.04M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $1.25M 10-Q · filed 2013-11-07 | $2.48M derived: sum of 2 quarters · filed 2013-11-07 | $3.74M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $1.23M 10-Q/A · filed 2013-10-21 | $2.48M 10-Q/A · filed 2013-10-21 | ||||||
| 2011-12-31 | $4.00M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |